Vivimed Labs’ FDF manufacturing facility located in Alathur, near Chennai had a favourable outcome post its US Food and Drug Administration (USFDA) inspection. The facility has successfully completed USFDA inspection. The audit was conducted during the last week of November and concluded on November 28, 2016.
Furthermore, Vivimed obtained ANDA approval for Metronidazole and same is commercialized. During November 2016, the company acquired ANDA of Zolpidem and the file transfer has successfully been completed. It is expected to be commercialized by Q4 FY2017. The company is on track of its filing targets and has successfully completed 3 ANDA filings during FY2017 and expects one more filing to be completed by Q4 FY2017. These products provide vertical integration with the in-house APIs.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
